News & Articles
Selected Filters:
Targeting protein-protein interactions (PPIs): Identifying PPI inhibitors for novel therapeutics
Dr. David Andrews, AstraZeneca, discusses the future of small-molecule drug discovery for PPIs
The importance of maintaining sample integrity throughout the COVID-19 pandemic
Amanda Kulwicki, Global Brand Manager at Thermo Fisher Scientific, discusses how her team ensures sample integrity with confidence
New data published from Women & Infants Hospital demonstrate utility of predictive immune modeling in ovarian cancer
This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future
Advance your research into the pathogenesis, diagnosis, and treatment of cancer
Explore our exclusive interviews and free resources to help support your cancer research, diagnostics, and therapy development
World-class speaker lineup announced for Virtual Cancer and Immunology Research Summit 2021
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions
New personalized therapeutics partner joins Repositive Cancer Model network
With this partnership, Repositive is expanding its personalized medicine capabilities to support more biopharma customers
Natera and Personalis partner for personalized monitoring in oncology
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring
The power of high-sensitivity troponin assays in the emergency department
Catch up on part one of our exclusive webinar series to hear Dr. Frank Peacock dispel the four lies of high-sensitivity troponin
Sysmex establishes new subsidiary in Portugal
Increasing Portuguese market presence by enhancing sales and after-sales support networks
Discover how to profile host responses in COVID-19 patients with ELLA SimplePlex
Join us on Friday, February 26, to find out how to effectively profile the host response to COVID-19 infection using the next-generation automated ELISA, Ella
The importance of pediatric reference intervals for diagnostic testing
Find out how to overcome the challenges involved with establishing reference intervals for clinical interpretation in this on-demand webinar
Pfizer and IDA Foundation partner to expand access to essential cancer treatments low-and middle-income countries
New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific
Mission Bio launches single-cell multi-omics system for faster development of precision cancer therapies
The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs
Technology Trends in Clinical Diagnostics and Research: The Very Best of 2018
Take a look back at the technologies, innovations and clinical advances that hit the headlines over the past 12 months
CAR T: Dual-targeted cell therapy to prevent relapsed multiple myeloma: Your questions answered
Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape
QIAGEN launches NeuMoDx multiplex test to complete range of SARS-CoV-2 testing solutions in Europe and other markets
Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing